TEEHAN BRENDAN 1891900 Data last updated 2024-05-11 06:58:14 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-19 | 2023-05-17 | 2023-05-17 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | dsp | 14869.0 | 37.91 | 0.91 | 22.5 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 24356.0 | 162.63 (ACAD) |
| 2023-05-19 | 2023-05-17 | 2023-05-17 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | acq | 29738.0 | 75.81 | 1.83 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 39225.0
|
162.63 (ACAD) |
| 2023-11-21 | 2023-11-17 | 2023-11-17 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | acq | 9912.0 | 28.04 | 0.6 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 35353.0
|
164.18 (ACAD) |
| 2023-11-21 | 2023-11-17 | 2023-11-20 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | dsp | 4960.0 | 14.03 | 0.3 | 22.64 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 30393.0 | 164.18 (ACAD) |
| 2024-01-09 | 2024-01-06 | 2024-01-08 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | dsp | 731.0 | 2.31 | 0.04 | 29.96 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 30949.0 | 164.18 (ACAD) |
| 2024-01-09 | 2024-01-06 | 2024-01-06 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | acq | 1287.0 | 4.06 | 0.08 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 31680.0 | 164.18 (ACAD) |
| 2024-02-27 | 2024-02-23 | 2024-02-23 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | acq | 1107.0 | 3.45 | 0.07 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 32056.0 | 164.18 (ACAD) |
| 2024-02-27 | 2024-02-23 | 2024-02-26 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | dsp | 624.0 | 1.95 | 0.04 | 24.67 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 31432.0 | 164.18 (ACAD) |
| 2024-03-27 | 2024-03-25 | 2024-03-27 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | dsp | 5140.0 | 12.39 | 0.31 | 17.9 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 36340.0 | 164.18 (ACAD) |
| 2024-03-27 | 2024-03-25 | 2024-03-25 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | acq | 10048.0 | 24.22 | 0.61 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code A | 41480.0 | 164.18 (ACAD) |
| 2024-04-09 | 2024-04-05 | 2024-04-05 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | acq | 5024.0 | 12.15 | 0.31 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 41364.0 | 164.18 (ACAD) |
| 2024-04-09 | 2024-04-05 | 2024-04-08 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | dsp | 2568.0 | 6.21 | 0.16 | 17.87 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 38796.0 | 164.18 (ACAD) |
| 2024-05-03 | 2024-05-01 | 2024-05-01 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | acq | 6814.0 | 14.94 | 0.42 | 0.0 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code M | 45610.0 | 164.18 (ACAD) |
| 2024-05-03 | 2024-05-01 | 2024-05-02 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | dsp | 3477.0 | 7.62 | 0.21 | 16.94 | Direct | Common Stock | ACADIA PHARMACEUTICALS INC | code S | 42133.0 | 164.18 (ACAD) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-19 | 2023-05-17 | 2023-05-17 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | dsp | 29738.0 | 54.55 | 1.83 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 24782.0
|
162.63 (ACAD) |
| 2023-11-21 | 2023-11-17 | 2023-11-17 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | dsp | 9912.0 | 33.33 | 0.6 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 19826.0
|
164.18 (ACAD) |
| 2024-01-09 | 2024-01-06 | 2024-01-06 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | dsp | 1287.0 | 100.0 | 0.08 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 0.0 | 164.18 (ACAD) |
| 2024-02-27 | 2024-02-23 | 2024-02-23 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | dsp | 1107.0 | 50.0 | 0.07 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 1107.0 | 164.18 (ACAD) |
| 2024-03-27 | 2024-03-25 | 2024-03-25 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | acq | 27460.0 | 100.0 | 1.67 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code A | 27460.0 | 164.18 (ACAD) |
| 2024-03-27 | 2024-03-25 | 2024-03-25 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | acq | 89516.0 | 100.0 | 5.45 | 17.84 | Direct | Stock Options (Right To Buy) | ACADIA PHARMACEUTICALS INC | code A | 89516.0 | 164.18 (ACAD) |
| 2024-04-09 | 2024-04-05 | 2024-04-05 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | dsp | 5024.0 | 33.33 | 0.31 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 10048.0 | 164.18 (ACAD) |
| 2024-05-03 | 2024-05-01 | 2024-05-01 | 4 | Teehan Brendan | EVP, COO, HEAD OF COMMERCIAL | dsp | 6814.0 | 25.0 | 0.42 | 0.0 | Direct | Restricted Stock Units | ACADIA PHARMACEUTICALS INC | code M | 20445.0 | 164.18 (ACAD) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)